DE60220179D1 - Substituierte benzopyrane als selektive agonisten am östrogenrezeptor-beta - Google Patents

Substituierte benzopyrane als selektive agonisten am östrogenrezeptor-beta

Info

Publication number
DE60220179D1
DE60220179D1 DE60220179T DE60220179T DE60220179D1 DE 60220179 D1 DE60220179 D1 DE 60220179D1 DE 60220179 T DE60220179 T DE 60220179T DE 60220179 T DE60220179 T DE 60220179T DE 60220179 D1 DE60220179 D1 DE 60220179D1
Authority
DE
Germany
Prior art keywords
estrogen receptor
receptor beta
substituted
benzopyranees
selective agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60220179T
Other languages
English (en)
Other versions
DE60220179T2 (de
Inventor
Jeffrey Alan Dodge
Venkatesh Gary Krishnan
Charles Willis Lugar
Blake Lee Neubauer
Bryan Hurst Norman
Lance Allen Pfeifer
Timothy Ivo Richardson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE60220179D1 publication Critical patent/DE60220179D1/de
Application granted granted Critical
Publication of DE60220179T2 publication Critical patent/DE60220179T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hematology (AREA)
  • Pyrane Compounds (AREA)
DE60220179T 2001-11-19 2002-11-07 Substituierte benzopyrane als selektive agonisten am östrogenrezeptor-beta Expired - Lifetime DE60220179T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33276601P 2001-11-19 2001-11-19
US332766P 2001-11-19
US36362202P 2002-03-11 2002-03-11
US363622P 2002-03-11
PCT/US2002/033622 WO2003044006A1 (en) 2001-11-19 2002-11-07 Substituted benzopyrans as selective estrogen receptor-beta agonists

Publications (2)

Publication Number Publication Date
DE60220179D1 true DE60220179D1 (de) 2007-06-28
DE60220179T2 DE60220179T2 (de) 2008-02-07

Family

ID=26988373

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60220179T Expired - Lifetime DE60220179T2 (de) 2001-11-19 2002-11-07 Substituierte benzopyrane als selektive agonisten am östrogenrezeptor-beta

Country Status (24)

Country Link
US (1) US7217734B2 (de)
EP (1) EP1448544B1 (de)
JP (1) JP4381810B2 (de)
KR (1) KR100950616B1 (de)
CN (1) CN1312147C (de)
AT (1) ATE362471T1 (de)
AU (1) AU2002359283B2 (de)
CA (1) CA2467013C (de)
CY (1) CY1106726T1 (de)
DE (1) DE60220179T2 (de)
DK (1) DK1448544T3 (de)
EA (1) EA007382B1 (de)
EC (1) ECSP045113A (de)
ES (1) ES2286322T3 (de)
HK (1) HK1068349A1 (de)
HR (1) HRP20040439A2 (de)
HU (1) HU229351B1 (de)
IL (3) IL161325A0 (de)
MX (1) MXPA04004703A (de)
NO (1) NO328563B1 (de)
NZ (1) NZ531850A (de)
PL (1) PL205733B1 (de)
PT (1) PT1448544E (de)
WO (1) WO2003044006A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1626974E (pt) 2003-04-21 2008-11-14 Lilly Co Eli Benzopiranos substituídos como agonistas selectivos do receptor beta de estrogénio
EP1618102B1 (de) 2003-04-21 2010-02-10 Eli Lilly And Company Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta
CA2578164A1 (en) 2004-09-07 2006-03-16 Wyeth 6h-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents
EP1805160B1 (de) * 2004-10-18 2011-04-06 Eli Lilly And Company Substituierte benzopyrane als selektive östrogenrezeptor-beta-agonisten
PL1812417T3 (pl) * 2004-11-18 2009-04-30 Janssen Pharmaceutica Nv Nowe pochodne 2H-chromenu jako selektywne modulatory receptora estrogenu
US8093302B2 (en) 2005-02-15 2012-01-10 Eli Lilly And Company Substituted tetralins as selective estrogen receptor-β agonists
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
TW201043595A (en) 2009-03-13 2010-12-16 Organon Nv Tetrahydronaphthalen-2-ol derivatives
US8063102B2 (en) 2009-03-13 2011-11-22 N.V. Organon Tetrahydronaphthalen-2-ol derivatives
CN105960236A (zh) 2013-12-05 2016-09-21 卡罗医药股份公司 用于治疗间皮瘤的雌激素受体β激动剂
AU2016324495B2 (en) 2015-09-17 2020-12-03 Institute Of Molecular Genetics As Cr, V.V.I. Carborane compounds and methods of use thereof
WO2021183760A1 (en) * 2020-03-11 2021-09-16 Ohio State Innovation Foundation Methods of modulating t-cell activation using estrogen receptor beta (erβ) agonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901926A (en) * 1973-04-02 1975-08-26 Abbott Lab Alkylphenyl benzopyrans
US5958710A (en) 1995-09-08 1999-09-28 Karo Bio Ab Orphan receptor
AU8102398A (en) * 1997-07-09 1999-02-08 Central Drug Research Institute (dl)-2,3-diaryl-2h-1-benzopyrans
US6593322B1 (en) 1999-03-17 2003-07-15 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
JP2003521468A (ja) 1999-03-17 2003-07-15 シグナル ファーマシューティカルズ， インコーポレイテッド エストロゲンレセプタを変調させるための化合物及び方法
SK14762001A3 (sk) 1999-04-16 2002-10-08 Astrazeneca Ab Ligandy receptora estrogénu beta
AU781282B2 (en) 1999-12-30 2005-05-12 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
WO2001064665A1 (en) * 2000-03-01 2001-09-07 Akzo Nobel N.V. Chroman derivatives as estrogenic compounds
US6686371B2 (en) 2000-03-27 2004-02-03 Akzo Nobel N.V. Non-steroidal, tetracylic compounds for estrogen-related treatments
GB2361642A (en) 2000-10-24 2001-10-31 Karobio Ab Estrogen receptor beta (ERbeta) agonists for use in cancer treatment
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
TWI306450B (en) 2001-12-13 2009-02-21 Wyeth Corp Substituted phenyl naphthalenes as estrogenic agents
US6630508B1 (en) * 2002-02-11 2003-10-07 Eli Lilly And Company Substituted benzopyrans as selective estrogen receptor β agonists

Also Published As

Publication number Publication date
KR100950616B1 (ko) 2010-04-01
AU2002359283B2 (en) 2007-06-21
DK1448544T3 (da) 2007-10-08
NZ531850A (en) 2007-01-26
JP2005513027A (ja) 2005-05-12
CN1589268A (zh) 2005-03-02
PL205733B1 (pl) 2010-05-31
KR20040063963A (ko) 2004-07-15
NO20042583L (no) 2004-06-18
MXPA04004703A (es) 2004-08-19
ECSP045113A (es) 2004-07-23
PL374510A1 (en) 2005-10-31
US7217734B2 (en) 2007-05-15
AU2002359283B8 (en) 2003-06-10
EP1448544B1 (de) 2007-05-16
CN1312147C (zh) 2007-04-25
IL161325A0 (en) 2004-09-27
ES2286322T3 (es) 2007-12-01
AU2002359283A1 (en) 2003-06-10
EA007382B1 (ru) 2006-10-27
PT1448544E (pt) 2007-08-10
HRP20040439A2 (en) 2005-04-30
HK1068349A1 (en) 2005-04-29
ATE362471T1 (de) 2007-06-15
HUP0402628A2 (hu) 2005-04-28
IL185867A0 (en) 2008-01-06
IL185867A (en) 2009-09-22
NO328563B1 (no) 2010-03-22
IL161325A (en) 2008-07-08
WO2003044006A1 (en) 2003-05-30
CY1106726T1 (el) 2012-05-23
US20040249167A1 (en) 2004-12-09
EP1448544A1 (de) 2004-08-25
HU229351B1 (en) 2013-11-28
CA2467013C (en) 2010-08-10
JP4381810B2 (ja) 2009-12-09
DE60220179T2 (de) 2008-02-07
CA2467013A1 (en) 2003-05-30
EA200400695A1 (ru) 2004-12-30

Similar Documents

Publication Publication Date Title
DE602004025460D1 (de) Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta
IL185867A0 (en) Substituted benzopyrans as selective estrogen receptor-beta agonists
CY1110443T1 (el) Υποκατεστημενα βενζοπυρανια ως εκλεκτικοι αγωνιστες υποδοχεα-βητα οιστρογονων
PT925301E (pt) Derivados altamente lipofilos de camptotecina
PT1200412E (pt) Agentes anti-proliferativos de imidazole
BR0215360A (pt) Derivados de indolina úteis como inibidores de proteìna quinase
ATE284388T1 (de) Cyclpentanoindole, mischungen derartige verbindungen enthaltend und behandlungsmethoden
BRPI0413234A (pt) derivados de imidazola bicìclica contra flaviviridae
MY141733A (en) Benzimidazole and pyridylimidazole derivatives as ligands for gabaa receptors
MXPA04002070A (es) Compuestos de indazol sustituidos para el tratamiento de la inflamacion.
DE60228484D1 (de) Cytotoxische mittel
ATE368040T1 (de) Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase- inhibitoren
DE60222465D1 (de) Pyrazolopyridin-derivate als antiherpesmittel
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
BR0014145A (pt) Compostos de benzimidazol substituìdo por alcóxi, preparações farmacêuticas contendo o mesmo, e métodos de uso do mesmo
SE9803107D0 (sv) Novel Compunds
SE9803277D0 (sv) Novel compounds
HN2001000165A (es) Derivados de imidazol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN